BOSTON, MASS. – June 21, 2005 - Pharm-Olam International (POI) has established a presence in Boston, Mass., with the goal of providing more personalized, customer satisfaction throughout the United States. Mark Anderson, Director of Business Development, will conduct business development activities in Boston. Anderson has been with POI since 2002 and in the clinical research industry since 1997—the majority, of which, has been in an operational capacity. He previously held the position of Business Development Manager, Europe and worked in POI's Ascot, England office.

Pharm-Olam International currently has a network of business development professionals throughout the United States and Europe. POI continues to experience substantial revenue growth and has established one of the largest, global, clinical research footprints.

Pharm-Olam International provides clinical research services to the pharmaceutical, biotechnology and medical device industries. POI is focused on delivering high-quality data, achieving targeted enrollment and meeting projected timelines. Please contact Pharm-Olam International Ltd. for more information. Focusing On Results.